delta 9-tetrahydrocannabinol in clinical oncology.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  1981-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.245.20.2047PMID 6262541
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.

  1980cited by this paper
• Marijuana for drug-induced nausea and vomiting.

  1980cited by this paper
• delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.

  1980cited by this paper
• AMELIORATION OF CANCER CHEMOTHERAPY‐INDUCED NAUSEA AND VOMITING BY DELTA‐9‐TETRAHYDRO‐CANNABINOL

  1979cited by this paper
• Tetrahydrocannabinol: from pot to prescription?

  1979cited by this paper
• delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.

  1979cited by this paper
• Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.

  1979cited by this paper
• Lack of cardiovascular effects of delta-9-tetrahydrocannabinol in chemically denervated men.

  1979cited by this paper
• Current status of marijuana research. Symposium on marijuana held july 1978 in Reims, France.

  1979cited by this paper
• Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.

  1979cited by this paper
• Nausea, vomiting and cancer treatment

  1978cited by this paper
• Marijuana use in schizophrenia: a clear hazard.

  1978cited by this paper
• Letter: Cancer treatment needs better antiemetics.

  1975cited by this paper
• Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.

  1975cited by this paper
• Inhibition of prostaglandin E2 biosynthesis by delta 1-tetrahydrocannabinol.

  1972cited by this paper

• Updates in Cancer Cachexia: Clinical Management and Pharmacologic Interventions

  2024cites this paper
• The effectiveness of Tai Chi on the depressive symptom of young adults with subthreshold depression: a study protocol for a randomized controlled trial

  2021cites this paper
• In vivo evaluation of the CB1 allosteric modulator LDK1258 reveals CB1-receptor independent behavioral effects.

  2019cites this paper
• A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics

  2017cites this paper
• Current and future care of patients with the cancer anorexia-cachexia syndrome.

  2015cites this paper
• Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.

  2015cites this paper
• Anticipatory nausea in animal models: a review of potential novel therapeutic treatments

  2014cites this paper
• Rôle des cellules immunitaires et effets des cannabinoïdes dans la physiopathologie des maladies à prions

  2008cites this paper
• Delta(9)-tetrahydrocannabinol Inhibits 17β-Estradiol-induced Proliferation and Fails to Activate Androgen and Estrogen Receptors in MCF7 Human Breast Cancer Cells

  2008cites this paper
• Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells.

  2008cites this paper
• Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa

  2008cites this paper
• On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).

  2007cites this paper
• On the Pharmacological Properties of Δ9‐Tetrahydrocannabinol (THC)

  2007cites this paper
• Cannabis use in HIV for pain and other medical symptoms.

  2005cites this paper
• Cannabinoids and cancer: causation, remediation, and palliation.

  2005cites this paper
• Activity of a new antiemetic agent: alizapride

  2004cites this paper
• Levonantradol, a new antiemetic with a high rate of side-effects for the prevention of nausea and vomiting in patients receiving cancer chemotherapy

  2004cites this paper
• The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans.

  2004cites this paper
• The good and the bad effects of (−) trans-delta-9-tetrahydrocannabinol (Δ9-THC) on humans

  2004cites this paper
• Medical Efficacy of Cannabinoids and Marijuana: A Comprehensive Review of the Literature

  2002cites this paper
• Prevention and Management of Chemotherapy-Induced Nausea and Vomiting, Part 2

  2001cites this paper
• Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

  2001cites this paper
• Pharmacology and potential therapeutic uses of cannabis.

  1998cites this paper
• Marijuana smoking vs cannabinoids for glaucoma therapy.

  1998cites this paper
• Cannabis: The Genus Cannabis

  1998cites this paper
• Medicinal Applications of Delta-9-Tetrahydrocannabinol and Marijuana

  1997cites this paper
• Marijuana to prevent nausea and vomiting in cancer patients: a survey of clinical oncologists.

  1997cites this paper
• Drug-Induced Ocular Side Effects

  1996cites this paper
• Gastric Motility Disturbances by Drugs

  1993cites this paper
• Update: pharmaceuticals and gastric emptying.

  1990cites this paper
• Clinical Features and Management of Intoxication Due to Hallucinogenic Drugs

  1989cites this paper
• Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial.

  1988cites this paper
• Inhalation marijuana as an antiemetic for cancer chemotherapy.

  1988cites this paper
• Attenuation of cyclophosphamide-induced taste aversions in mice by prochlorperazine, delta 9-tetrahydrocannabinol, nabilone and levonantradol.

  1985cites this paper
• Library collection of the psychosocial publications in consultation-liaison psychiatry.

  1985cites this paper
• Control of common physical symptoms other than pain in patients with terminal disease.

  1985cites this paper
• THE CONTROL OF CANCER CHEMOTHERAPY‐INDUCED NAUSEA AND VOMITING

  1985cites this paper
• A versatile approach to analogues of the cannabinoid‐like anti‐emetic nonabine (BRL 4664)

  1984cites this paper
• The physiology and pharmacology of emesis.

  1984cites this paper
• Delta-9-tetrahydrocannabinol and gastric emptying.

  1983cites this paper
• Drugs related to tetrahydrocannabinol

  1983cites this paper
• A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa.

  1983cites this paper
• Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues.

  1983cites this paper
• Soma and psyche.

  1983cites this paper
• [Phase I study of alizapride in cancer patients treated with cisplatin].

  1983cites this paper
• Analgesic interaction between nitrous oxide and delta-9-tetrahydrocannabinol in the rat.

  1983cites this paper
• delta 9-Tetrahydrocannabinol and therapeutic research legislation for cancer patients.

  1983cites this paper
• Therapeutic potential of cannabinoids.

  1982cites this paper
• [High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients].

  1982cites this paper
• Anticipatory nausea and vomiting associated with cancer chemotherapy.

  1982cites this paper
• Behavioral intervention in cancer treatment: controlling aversion reactions to chemotherapy.

  1982cites this paper
• Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine.

  1982cites this paper
• Controlling chemotherapy side effects.

  1982cites this paper
• MARIJUANA AND THE EYE - A REVIEW

  1982cites this paper